Net benefit of ivacaftor during prolonged tezacaftor/elexacaftor exposure in vitro is a research paper published in Journal of Cystic Fibrosis (2022). On theSindex it has a DataRank of 0. It has been cited 5 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Heart Lung and Blood Institute
Grant: F32HL158174
National Heart Lung and Blood Institute
Grant: R01HL155325
Cystic Fibrosis Foundation
Grant: BRATCH16I0
Cystic Fibrosis Foundation
Grant: BRATCH21I0
Cystic Fibrosis Foundation
Grant: ZEITLI2010
National Institutes of Health
Grant: 1F32HL158174-01
Prostones as novel receptor-mediated activators of CFTR in the airway
National Institutes of Health
Grant: 5R01HL155325-02
Contribution of pulmonary ionocytes and neuroendocrine cells to ion transport-mediated airway surface liquid maintenance
National Institutes of Health
FWCI
0.68
Citation Percentile
0.7%
Citation Trend
Fields of Study
MeSH Terms
Keywords